EUVIMEDOpdag EUVIMED
Crossref

Exploring the Mechanisms of Resveratrol in ARDS Treatment: From Network Pharmacology and Molecular Docking to In Vitro Validation

Zhili Zhang, Wanting Hu iD, Xixi Cong, Junjie Zhang, Siyu Sun, Meng Qin, Weiping Zhang, Ying Yu iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70187 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2025. Written by Zhili Zhang and 7 co-authors. Institution: Basic and Clinical Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical University, Bengbu, China. Major MEDLINE topics: Resveratrol, Molecular Docking Simulation, Respiratory Distress Syndrome. 61 references. Funded by: the Natural Science Foundation of Anhui Province, the Natural Science Foundation of the Education Department of Anhui Province, 512 Talent Cultivation Plan of Bengbu Medical College.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Acute respiratory distress syndrome (ARDS) is a severe and critical clinical pulmonary disease. Resveratrol (RES), a non‐flavonoid polyphenolic compound, has shown potential therapeutic effects. However, the underlying mechanism of RES treatment for ARDS remains unclear. This study employed network pharmacology to predict potential targets and metabolic pathways involved in RES treatment for ARDS. Molecular docking and experimental validation were performed to confirm key targets and metabolic pathways. A comprehensive database search identified 115 RES‐ARDS‐related targets. Subsequently, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses highlighted the JAK/STAT pathway, which was further investigated with RES in the treatment of ARDS. Hematoxylin–eosin (HE) staining visualized lung damage. Western blot analysis showed that RES significantly downregulated p‐JAK2, NLRP3, IL‐18, and p‐STAT3 expression ( p < 0.05). A variety of animal experiments have substantiated that RES can effectively inhibit inflammation and oxidative stress, and promote blood barrier repair. In conclusion, this study provides new insights into the protective mechanism of RES against ARDS, highlighting its potential as a therapeutic agent.

Subjects

MeSH terms (MEDLINE)

ResveratrolMolecular Docking SimulationRespiratory Distress SyndromeAnimalsNetwork PharmacologyHumansSTAT3 Transcription FactorJanus Kinase 2Oxidative StressSignal TransductionMaleMiceInterleukin-18

Author keywords

Janus kinase 2 (JAK2)acute respiratory distress syndrome (ARDS)molecular dockingnetwork pharmacologyresveratrolsignal transducer and activator of transcription 3 (STAT3)

Substances

ResveratrolSTAT3 Transcription FactorJanus Kinase 2Interleukin-18

Authors and institutions

  • Basic and Clinical Key Laboratory of Cardiovascular and Cerebrovascular Diseases, Bengbu Medical University, Bengbu, China.
  • Department of Physiology, School of Basic Medicine, Bengbu Medical University, Bengbu, China.

ORCID profiles: Wanting Hu, Ying Yu

Funding

  • the Natural Science Foundation of Anhui Province
  • the Natural Science Foundation of the Education Department of Anhui Province
  • 512 Talent Cultivation Plan of Bengbu Medical College
  • National College Students Innovation and Entrepreneurship Training Program
  • Natural Science Foundation of Anhui Province

Cite

APA

Zhang, Z., Hu, W., Cong, X., Zhang, J., Sun, S., Qin, M., Zhang, W., & Yu, Y. (2025). Exploring the Mechanisms of Resveratrol in ARDS Treatment: From Network Pharmacology and Molecular Docking to In Vitro Validation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70187

Vancouver

Zhang Z, Hu W, Cong X, Zhang J, Sun S, Qin M, et al. Exploring the Mechanisms of Resveratrol in ARDS Treatment: From Network Pharmacology and Molecular Docking to In Vitro Validation. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70187

BibTeX
@article{Zhang2025,
  author = {Zhang, Zhili and Hu, Wanting and Cong, Xixi and Zhang, Junjie and Sun, Siyu and Qin, Meng and Zhang, Weiping and Yu, Ying},
  title = {Exploring the Mechanisms of Resveratrol in ARDS Treatment: From Network Pharmacology and Molecular Docking to In Vitro Validation},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70187}
}
Start for free →